A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Hoffmann-La Roche
Bayer
Merck Sharp & Dohme LLC
Convalife (Shanghai) Co., Ltd.
Universitair Ziekenhuis Brussel
Hoffmann-La Roche
National Cancer Institute (NCI)
National Cancer Institute (NCI)